In Vitro Pharmacology of KB407, an HSV-1-Based Gene Therapy Vector, for the Treatment of Cystic Fibrosis

被引：0
|
作者：
Freedman, Court [1 ]
Parry, Trevor [1 ]
Agarwal, Pooja [1 ]
de l'Hortet, Alexandra Collin [1 ]
Krishnan, Suma [1 ]
机构：
[1] Krystal Biotech Inc, Pittsburgh, PA USA
来源：
MOLECULAR THERAPY | 2020年 / 28卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
282
引用
收藏
页码：131 / 132
页数：2
相关论文
共 11 条
  • [1] Evaluation of KB407, An HSV-1-Based Gene Therapy Vector for the Treatment of Cystic Fibrosis, in Healthy and Patient-Derived Airway Cells Including an Apical-out Diseased Airway Organoid Model
    Artusi, S.
    Guzman-Lepe, J.
    Duermeyer, M. J.
    Parry, T. J.
    Krishnan, S. M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
  • [2] Preclinical pharmacology of KB408, an HSV-1-based gene therapy vector, for the treatment of alpha-1 antitrypsin deficiency
    Artusi, S.
    Zhang, P.
    Duermeyer, M. J.
    Parry, T.
    Krishnan, S.
    HUMAN GENE THERAPY, 2021, 32 (19-20) : A40 - A40
  • [3] Preclinical safety and pharmacology of KB105, an HSV-based gene therapy vector for the treatment of autosomal recessive congenital ichthyosis (ARCI)
    Zhang, P.
    Majumdar, A.
    Freedman, C.
    Yogesha, S.
    Ramasamy, S.
    Krishnan, S.
    Agarwal, P.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2019, 139 (05) : S66 - S66
  • [4] Murine Toxicology Study of Repeat-Dose Inhaled KB408, an HSV-1-Based Vector for the Treatment of Alpha-1 Antitrypsin Deficiency
    Artusi, S.
    Duermeyer, M. J.
    Vaughn, M. F.
    Chen, H.
    Parry, T. J.
    Krishnan, S. M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
  • [5] KB104: an HSV-based gene therapy vector engineered to deliver functional SPINK5 for the treatment of Netherton Syndrome
    Bustos, M.
    Freedman, C.
    Majumdar, A.
    Zhang, P.
    Parry, T.
    Coghlan, S.
    Krishnan, S.
    Agarwal, P.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2019, 139 (05) : S66 - S66
  • [6] Respiratory Syncytial Virus Based Gene Therapy Vectors for the Treatment of Cystic Fibrosis
    Kwilas, Anna R.
    Yednak, Mark A.
    Zhang, Liquin
    Collins, Peter L.
    Pickles, Raymond J.
    Peeples, Mark E.
    MOLECULAR THERAPY, 2009, 17 : S312 - S312
  • [7] Is intercellular trafficking an internal property of HSV-1VP22 and can it be used towards cystic fibrosis gene therapy?
    Chatzidaki, E
    Wiseman, JW
    Colledge, WH
    MOLECULAR THERAPY, 2003, 7 (05) : S373 - S373
  • [8] KB105: An HSV-based gene therapy vector engineered to deliver functional TGM1 to Autosomal Recessive Congenital Ichthyosis (ARCI) keratinocytes
    Freedman, C.
    Majumdar, A.
    Zhang, P.
    Krishnan, S.
    Agarwal, P.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2019, 139 (05) : S65 - S65
  • [9] Fetal gene therapy via the cerebrospinal fluid using an HSV-1 amplicon cosmid based vector
    Patino, W
    Breakefield, XO
    Larsen, JW
    Kwok, A
    Andry, C
    Lebo, RV
    AMERICAN JOURNAL OF HUMAN GENETICS, 2002, 71 (04) : 583 - 583
  • [10] Combination treatment of fiber-modified adenovirus based HSV-1 thymidine kinase/ganciclovir gene therapy with docetaxel for bladder cancer
    Yamashita, Hideyuki
    Jian, Weigo
    Gilbert, April
    Lerner, Seth P.
    JOURNAL OF UROLOGY, 2007, 177 (04): : 294 - 294
12